Cognitive-Behavioral Therapy for Sleep Disturbance in Patients Undergoing Peritoneal Dialysis: A Pilot Randomized Controlled Trial

American Journal of Kidney Diseases

Volumn 52, Issue 2, 2008, Pages 314-323

  Chen, Hung Yuan ^a,b   Chiang, Chih Kang ^b   Wang, Hsi Hao ^c   Hung, Kuan Yu ^b   Lee, Yue Joe ^b   Peng, Yu Sen ^a,b   Wu, Kwan Dun ^b   Tsai, Tun Jun ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

Author keywords

Cognitive behavioral therapy; insomnia; interleukin 1 ; interleukin 18; tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; EDUCATION; FATIGUE; FEMALE; HEALTH CENTER; HUMAN; INSOMNIA; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PSYCHIATRIST; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER;

COGNITIVE THERAPY; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PILOT PROJECTS; PROSPECTIVE STUDIES; SLEEP; SLEEP DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 47349115810     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.03.012     Document Type: Article

References (30)

1. Novak M., Shapiro C.M., Mendelssohn D., and Mucsi I. Diagnosis and management of insomnia in dialysis patients. Semin Dial 19 (2006) 25-31
2. Iliescu E.A., Yeates K.E., and Holland D.C. Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant 19 (2004) 95-99
3. Mucsi I., Molnar M.Z., Ambrus C., et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 20 (2005) 571-577
4. Unruh M.L., Levey A.S., D'Ambrosio C., et al. Restless legs symptoms among incident dialysis patients: Association with lower quality of life and shorter survival. Am J Kidney Dis 43 (2004) 900-909
5. Barbera J., and Shapiro C. Benefit-risk assessment of zaleplon in the treatment of insomnia. Drug Saf 28 (2005) 301-318
6. Montgomery P., and Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev (2003) CD003161
7. Savard J., Simard S., Ivers H., and Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 23 (2005) 6083-6096
8. Jacobs G.D., Pace-Schott E.F., Stickgold R., and Otto M.W. Cognitive behavior therapy and pharmacotherapy for insomnia: A randomized controlled trial and direct comparison. Arch Intern Med 164 (2004) 1888-1896
9. Buysse D.J., Reynolds III C.F., Monk T.H., Berman S.R., and Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193-213
10. Opp M.R. Cytokines and sleep. Sleep Med Rev 9 (2005) 355-364
11. Kubota T., Fang J., Brown R.A., and Krueger J.M. Interleukin-18 promotes sleep in rabbits and rats. Am J Physiol Regul Integr Comp Physiol 281 (2001) R828-R838
12. Erten Y., Kokturk O., Yuksel A., et al. Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients. Nephrology (Carlton) 10 (2005) 330-335
13. Savard J., Simard S., Ivers H., and Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: Immunologic effects. J Clin Oncol 23 (2005) 6097-6106
14. Jacobs G.D., Benson H., and Friedman R. Perceived benefits in a behavioral-medicine insomnia program: A clinical report. Am J Med 100 (1996) 212-216
15. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
16. Herlofson K., and Larsen J.P. Measuring fatigue in patients with Parkinson's disease-The Fatigue Severity Scale. Eur J Neurol 9 (2002) 595-600
17. Tsai P.S., Wang S.Y., Wang M.Y., et al. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res 14 (2005) 1943-1952
18. Li F., Fisher K.J., Harmer P., et al. Tai chi and self-rated quality of sleep and daytime sleepiness in older adults: A randomized controlled trial. J Am Geriatr Soc 52 (2004) 892-900
19. Sivertsen B., Omvik S., Pallesen S., et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: A randomized controlled trial. JAMA 295 (2006) 2851-2858
20. Edinger J.D., Wohlgemuth W.K., Radtke R.A., Marsh G.R., and Quillian R.E. Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. JAMA 285 (2001) 1856-1864
21. Yang J.Y., Huang J.W., Chiang C.K., et al. Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients. Nephrol Dial Transplant 22 (2007) 3606-3609
22. Walsh J.K., and Schweitzer P.K. Ten-year trends in the pharmacological treatment of insomnia. Sleep 22 (1999) 371-375
23. Friedman E.M., Hayney M.S., Love G.D., et al. Social relationships, sleep quality, and interleukin-6 in aging women. Proc Natl Acad Sci U S A 102 (2005) 18757-18762
24. Cohen L., Warneke C., Fouladi R.T., Rodriguez M.A., and Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100 (2004) 2253-2260
25. Tench C.M., McCarthy J., McCurdie I., White P.D., and D'Cruz D.P. Fatigue in systemic lupus erythematosus: A randomized controlled trial of exercise. Rheumatology (Oxford) 42 (2003) 1050-1054
26. Yoshida H., Peterfi Z., Garcia-Garcia F., et al. State-specific asymmetries in EEG slow wave activity induced by local application of TNFalpha. Brain Res 1009 (2004) 129-136
27. Imeri L., Bianchi S., and Mancia M. Muramyl dipeptide and IL-1 effects on sleep and brain temperature after inhibition of serotonin synthesis. Am J Physiol 273 (1997) R1663-R1668
28. Cannon J.G., Angel J.B., Abad L.W., et al. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 17 (1997) 253-261
29. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., and Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 (2005) 255-269
30. Naito Y., Tsujino T., Fujioka Y., et al. Increased circulating interleukin-18 in patients with congestive heart failure. Heart 88 (2002) 296-297